β blockers and mortality after myocardial infarction in patients without heart failure: Multicentre prospective cohort study

BMJ (Online)

Volumn 354, Issue , 2016, Pages

  Puymirat, Etienne ^a,b,c   Riant, Elisabeth ^a,b,c   Aissoui, Nadia ^a,b,c   Soria, Angèle ^b,d,e,f   Ducrocq, Gregory ^b,c,f,g   Coste, Pierre ^h,i   Cottin, Yves ^j,k   Aupetit, Jean François ^l   Bonnefoy, Eric ^m,n   Blanchard, Didier ^o   Cattan, Simon ^p   Steg, Gabriel ^b,c,f,g   Schiele, François ^q,r   Ferrières, Jean ^s,t   Juillière, Yves ^u,v   Simon, Tabassome ^b,w   Danchin, Nicolas ^a,b,c  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL TENON   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f INSERM   (France)

^g BICHAT HOSPITAL   (France)

^h HAUT LÉVÊQUE HOSPITAL   (France)

ⁱ UNIVERSITÉ DE BORDEAUX   (France)

^j HÔPITAL DU BOCAGE   (France)

^k UNIVERSITÉ DE BOURGOGNE   (France)

^l CENTRE HOSPITALIER SAINT JOSEPH SAINT LUC   (France)

^m LOUIS PRADEL HOSPITAL   (France)

ⁿ UNIVERSITÉ LYON 1   (France)

^o Clinique Saint Gatien   (France)

^p Groupe Hospitalier Intercommunal Le Raincy Montfermeil   (France)

^q UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^r UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^s TOULOUSE UNIVERSITY HOSPITAL   (France)

^t Faculté de Médecine Centre Hospitalo universitaire   (France)

^u Institut Lorrain du C ur et des Vaisseaux   (France)

^v UNIVERSITÉ DE LORRAINE   (France)

^w HÔPITAL SAINT ANTOINE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; EARLY INTERVENTION; FEMALE; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT WITHDRAWAL; ACUTE DISEASE; CLINICAL TRIAL; CORONARY CARE UNIT; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; TIME FACTOR;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; AGED; CORONARY CARE UNITS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT DISCHARGE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84988904353     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i4801     Document Type: Article

References (24)

1. Brophy JM, Joseph L, Rouleau JL. Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med 2001;134:550-60. doi:10.7326/0003-4819-134-7-200104030-00008.
2. Fauchier L, Pierre B, de Labriolle A, Babuty D. Comparison of the beneficial effect of beta-blockers on mortality in patients with ischaemic or non-ischaemic systolic heart failure: a meta-analysis of randomised controlled trials. Eur J Heart Fail 2007;9:1136-9. doi:10.1016/j.ejheart.2007.09.003.
3. Freemantle N, Cleland J, Young P, Mason J, Harrison J. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999;318:1730-7. doi:10.1136/bmj.318.7200.1730.
4. Chen ZM, Pan HC, Chen YP, et al. COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:1622-32. doi:10.1016/S0140-6736(05)67661-1.
5. Hamm CW, Bassand J-P, Agewall S, et al. European Society of Cardiology. [ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)].G Ital Cardiol (Rome) 2006;2012:171-228.
6. Anderson JL, Adams CD, Antman EM, et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:e179-347. doi:10.1016/j.jacc.2013.01.014.
7. OGara PT, Kushner FG, Ascheim DD, et al. American College of Emergency Physicians Society for Cardiovascular Angiography and Interventions. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:e78-140. doi:10.1016/j.jacc.2012.11.019.
8. Steg PG, James SK, Atar D, et al. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-619. doi:10.1093/eurheartj/ehs215.
9. Bangalore S, Makani H, Radford M, et al. Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials. Am J Med 2014;127:939-53. doi:10.1016/j.amjmed.2014.05.032.
10. Cambou J-P, Simon T, Mulak G, Bataille V, Danchin N. The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics. Arch Mal Coeur Vaiss 2007;100:524-34.
11. Danchin N, Puymirat E, Steg PG, et al. FAST-MI 2005 Investigators. Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort. Circulation 2014;129:1629-36. doi:10.1161/CIRCULATIONAHA.113.005874.
12. Van de Werf F, Bax J, Betriu A, et al. ESC Committee for Practice Guidelines (CPG). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909-45. doi:10.1093/eurheartj/ehn416.
13. Antman EM, Anbe DT, Armstrong PW, et al. American College of Cardiology American Heart Association Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004;44:671-719. doi:10.1016/j. jacc.2004.07.002.
14. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998;339:489-97. doi:10.1056/NEJM199808203390801.
15. Emery M, Lopez-Sendon J, Steg PG, et al. GRACE Investigators. Patterns of use and potential impact of early beta-blocker therapy in non-ST-elevation myocardial infarction with and without heart failure: the Global Registry of Acute Coronary Events. Am Heart J 2006;152:1015-21. doi:10.1016/j.ahj.2006.08.024.
16. Choo EH, Chang K, Ahn Y, et al. Benefit of β-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention. Heart 2014;100:492-9. doi:10.1136/heartjnl-2013-305137.
17. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006;166:1842-7. doi:10.1001/archinte.166.17.1842.
18. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007;297:177-86. doi:10.1001/jama.297.2.177.
19. Bangalore S, Steg G, Deedwania P, et al. REACH Registry Investigators. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA 2012;308:1340-9. doi:10.1001/jama.2012.12559.
20. Goldberger JJ, Bonow RO, Cuffe M, et al. OBTAIN Investigators. Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction. J Am Coll Cardiol 2015;66:1431-41. doi:10.1016/j.jacc.2015.07.047.
21. Andersson C, Shilane D, Go AS, et al. β-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease. J Am Coll Cardiol 2014;64:247-52. doi:10.1016/j.jacc.2014.04.042.
22. Fonarow GC, French WJ, Parsons LS, Sun H, Malmgren JA. Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3. Circulation 2001;103:38-44. doi: 10.1161/01. CIR.103.1.38.
23. Dormuth CR, Patrick AR, Shrank WH, et al. Statin adherence and risk of accidents: a cautionary tale. Circulation 2009;119:2051-7. doi:10.1161/CIRCULATIONAHA.108.824151.
24. Danchin N, Neumann A, Tuppin P, et al. Impact of free universal medical coverage on medical care and outcomes in low-income patients hospitalized for acute myocardial infarction: an analysis from the FrenchNational Health Insurance system. Circ Cardiovasc Qual Outcomes 2011;4:619-25. doi:10.1161/CIRCOUTCOMES.111.961193.